A examine posted in JAMA Community Open up emphasizes the discrepancy among what it fees to generate copyright and also the retail charges patients confront. Despite the very low manufacturing fees, Novo Nordisk hasn't publicly disclosed particular figures for copyright or its other product, Wegovy.But Rybelsus and copyright do have some variations